'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
Read more on NPR
Health & Science - September 4, 2020 at 04:00PM - 'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
Không có nhận xét nào:
Đăng nhận xét